Ninth international symposium on radiopharmacology
The goal of this Symposium is to provide a forum for those international scientists involved in applying the principles of pharmacology and radiation biology to the development of agents for the diagnosis and treatment of disease. The program will highlight state-of-the-art progress in the development of those agents used in conjunction with some form of radiation such as radiopharmaceuticals, radiopaques, photo- and radiosensitizing drugs, and neutron capture agents. An underlying pharmacokinetic parameter associated with all these agents is the need for site-specific delivery to an organ or tumor. Therefore, a major goal of the symposium will be to address those pharmacologic principles for targeting molecules to specific tissue sites. Accordingly, session themes will include receptor-mediated processes, membrane transporters, antibody interactions, metabolic trapping, and oligonucleotide-antisense mechanisms.
- Research Organization:
- Michigan Univ., Ann Arbor, MI (United States). Medical Center
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- FG02-95ER62034
- OSTI ID:
- 392796
- Report Number(s):
- DOE/ER/62034-1; CONF-9506389-; ON: DE96014846; TRN: 97:000050
- Resource Relation:
- Conference: 9. international symposium on radiopharmacology, Ann Arbor, MI (United States), 7-10 Jun 1995; Other Information: PBD: 1995
- Country of Publication:
- United States
- Language:
- English
Similar Records
Genetically engineered multivalent single chain antibody constructs for cancer therapy
WE-A-16A-01: International Medical Physics Symposium: Increasing Access to Medical Physics Education/Training and Research Excellence